Barbara Ann Karmanos Cancer Institute Site#159 — Detroit, Michigan

Barbara Ann Karmanos Cancer Institute Site#159 is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Barbara Ann Karmanos Cancer Institute Site#159 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Relapsed/Refractory Peripheral T-cell Lymphoma.

Sponsors: Taiho Oncology, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Barbara Ann Karmanos Cancer Institute Site#159?

Barbara Ann Karmanos Cancer Institute Site#159 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Barbara Ann Karmanos Cancer Institute Site#159 conducted?

Barbara Ann Karmanos Cancer Institute Site#159 has 1 clinical trials on record, with 1 currently active. Their work covers Relapsed/Refractory Peripheral T-cell Lymphoma.

Is Barbara Ann Karmanos Cancer Institute Site#159 accredited by Crixeo Health?

Barbara Ann Karmanos Cancer Institute Site#159 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Barbara Ann Karmanos Cancer Institute Site#159?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.